221 related articles for article (PubMed ID: 10682906)
1. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR; Sferra TJ; Lo W; Qu G; Chen R; Johnson PR
J Drug Target; 1999 Dec; 7(4):269-83. PubMed ID: 10682906
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer by adeno-associated virus vectors into the central nervous system.
Xiao X; Li J; McCown TJ; Samulski RJ
Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
[TBL] [Abstract][Full Text] [Related]
3. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vectors for vascular gene delivery.
Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL
Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model.
Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH
Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.
Sarukhan A; Soudais C; Danos O; Jooss K
J Gene Med; 2001; 3(3):260-70. PubMed ID: 11437331
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the fate of rAAV genomes following in vivo administration.
Clark KR; Penaud-Budloo M
Methods Mol Biol; 2011; 807():239-58. PubMed ID: 22034033
[TBL] [Abstract][Full Text] [Related]
8. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
[TBL] [Abstract][Full Text] [Related]
10. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.
McCarty DM; Fu H; Monahan PE; Toulson CE; Naik P; Samulski RJ
Gene Ther; 2003 Dec; 10(26):2112-8. PubMed ID: 14625565
[TBL] [Abstract][Full Text] [Related]
12. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
Chadeuf G; Ciron C; Moullier P; Salvetti A
Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
[TBL] [Abstract][Full Text] [Related]
13. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
[TBL] [Abstract][Full Text] [Related]
15. Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium.
Tsai ML; Chen SL; Chou PI; Wen LY; Tsai RJ; Tsao YP
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):751-7. PubMed ID: 11867594
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury.
Galeano M; Deodato B; Altavilla D; Squadrito G; Seminara P; Marini H; Stagno d'Alcontres F; Colonna M; Calò M; Lo Cascio P; Torre V; Giacca M; Venuti FS; Squadrito F
Crit Care Med; 2003 Apr; 31(4):1017-25. PubMed ID: 12682466
[TBL] [Abstract][Full Text] [Related]
17. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.
Pacak CA; Mah CS; Thattaliyath BD; Conlon TJ; Lewis MA; Cloutier DE; Zolotukhin I; Tarantal AF; Byrne BJ
Circ Res; 2006 Aug; 99(4):e3-9. PubMed ID: 16873720
[TBL] [Abstract][Full Text] [Related]
18. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus-based vectors provide short-term rather than long-term transduction of primitive hematopoietic stem cells.
van Os R; Avraham H; Banu N; Mauch PM; Whater J; Yang Y; Du B
Stem Cells; 1999; 17(2):117-20. PubMed ID: 10195572
[TBL] [Abstract][Full Text] [Related]
20. Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells.
Gnatenko D; Arnold TE; Zolotukhin S; Nuovo GJ; Muzyczka N; Bahou WF
J Investig Med; 1997 Feb; 45(2):87-98. PubMed ID: 9084579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
